Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882050 · ClinicalTrials.gov registry record · Phase 1
Intravenous Exenatide (Byetta) During Surgery
A Phase 1 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 1
- Development phase
- 104
- Enrollment target
NCT00882050 is a Phase 1 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 104 participants.
The verdict
NCT00882050, a Phase 1 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this project is to study if intravenous Exenatide is effective at maintaining normal blood glucose levels and preventing low blood glucose levels during surgery.
Interventions
- DRUG Placebo
- DRUG Exenatide 0.27 ng/kg/min
- DRUG Exenatide 0.41 ng/kg/min
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00882050
The ClinicalTrials.gov registry entry for NCT00882050 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00882050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00882050 about?
NCT00882050 is a clinical study titled "Intravenous Exenatide (Byetta) During Surgery". The purpose of this project is to study if intravenous Exenatide is effective at maintaining normal blood glucose levels and preventing low blood glucose levels during surgery.
What is the current status of trial NCT00882050?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 104 participants. The study started on 2009-03. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00882050?
The interventions under investigation include: Placebo (DRUG), Exenatide 0.27 ng/kg/min (DRUG), Exenatide 0.41 ng/kg/min (DRUG).
Who is sponsoring clinical trial NCT00882050?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.